CentoBrief 08/2014


Extended test portfolio :: Visit us at ASHG at booth #1220 :: Extended EXTAN® kits

Visit us at ASHG 2014 and learn more about our mutation database

Meet our experts at booth #1220 at the upcoming Annual Meeting of the American Society of Human Genetics, taking place in San Diego Oct 18-22.
Get the latest insights into our broad product portfolio including innovative methods such as whole exome sequencing (WES) combined with advanced end-to-end bioinformatic analysis and linked to CentoMD®, our comprehensive mutation database.

News on genes & panels

Updated test portfolio

Centogene has recently added new single gene tests and NGS panels to its portfolio, constantly following the most actual scientific developments. Our NGS panel composition always reflects the clinical relevance to the specific disease phenotype, processed with a standardized quality scheme and internal controls.

Please have a deeper look at our CentoBrief October 2014 for new single gene analyses and
new NGS panels.
To see all of our recently added single gene tests or NGS panels, please download pdf here.

Centogene insights

Extended EXTAN® product line

Centogene has extended its EXTAN® product line for oncology, neurology, cardiology, nephrology and many more (download pdf).

What is Extan®?

  • An extensively validated CE labeled in vitro diagnostic kit for a broad spectrum of diagnostically relevant genes
  • A set of bidirectional primers with controls to sequence the entire coding region
  • An affordable solution to rapidly and reliably expand your test portfolio

EXTAN® kits are an affordable solution to allow laboratories worldwide to rapidly increase their test portfolio using a validated set of primers, controls and protocols.

To find out  more about the advantages of using EXTAN®, please download our brochure, visit our website or contact extan(at)centogene(dot)com.

If you have any questions or comments, please do not hesitate to contact us

Best regards,

Doreen Niemann
Senior Director Strategic Communication
Centogene AG


Centogene AG
Schillingallee 68
18057 Rostock


Responsible: Doreen Niemann
USt-IdNr.: DE813228872